Related Experiment Video
Updated: Nov 5, 2025

04:25
Author Spotlight: Bridging Gaps in Anatomy and Establishing a Foundation for Algorithmic Studies
Published on: December 15, 2023
3.2K
Implications of COVID-19 in Neurological Disorders
1Baylor Scott & White Medical Center-Centennial Hospital, Frisco, TX 75035, USA.
Journal of Neurology Research
|May 13, 2021
Summary
The COVID-19 pandemic significantly impacted neurology services. This review discusses these effects and proposes strategies to maintain high-quality neurological care during the pandemic.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic has disrupted healthcare systems globally.
- Neurological conditions require continuous management and specialized care.
- The pandemic necessitated rapid adaptation in healthcare delivery across medical specialties.
Purpose of the Study:
- To review the multifaceted impact of COVID-19 on the field of neurology.
- To identify challenges faced in managing various neurological diseases during the pandemic.
- To propose adaptive strategies for sustained neurological healthcare delivery.
Main Methods:
- Literature review of studies on COVID-19's impact on neurology.
- Analysis of changes in clinical practice for neurological disorders.
- Synthesis of recommendations for pandemic-era neurological care.
Main Results:
- Significant disruptions in routine neurological care, including elective procedures and follow-up appointments.
- Increased challenges in diagnosing and managing acute neurological conditions.
- Adaptations included telemedicine, modified treatment protocols, and enhanced safety measures.
- Specific impacts noted across diverse neurological diseases, from stroke to neurodegenerative disorders.
Conclusions:
- The COVID-19 pandemic presented unprecedented challenges to neurological practice.
- Proactive adaptation and strategic planning are crucial for maintaining essential neurological services.
- Implementing innovative healthcare models ensures patient safety and continuity of care for neurological conditions.
Related Concept Videos
Disorders of the Nervous Tissue
2.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.1K
Parkinson's Disease: Overview
1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K
Neural Regulation
40.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.9K
Excitatory and Inhibitory Effects of Neurotransmitters
11.7K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
11.7K

